Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells

Tissue Engineering - Part A

Volumn 19, Issue 19-20, 2013, Pages 2253-2266

  Russell, Katie C ^a,b   Tucker, H Alan ^b   Bunnell, Bruce A ^b   Andreeff, Michael ^c   Schober, Wendy ^c   Gaynor, Andrew S ^a   Strickler, Karen L ^a,b   Lin, Shuwen ^a   Lacey, Michelle R ^a   O'Connor, Kim C ^a,b  

^a Tulane University   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOMOLECULES; CELL PROLIFERATION; CELLS; DERMATOLOGY; FLOW CYTOMETRY; FLOWCHARTING; ONCOLOGY;

ANTIGEN EXPRESSION; CELL SURFACE EXPRESSION; COLONY-FORMING EFFICIENCY; FLUORESCENCE ACTIVATED CELL SORTING; MESENCHYMAL STEM CELL; REGENERATIVE MEDICINE; SELECTION CRITERIA; SURFACE EXPRESSION;

CELL CULTURE;

ANTIGEN; CD146 ANTIGEN; NEURON GLIAL ANTIGEN 2; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIVISION; CELL POPULATION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MULTIPOTENT STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS; ANTIGENS, CD146; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; PROTEOGLYCANS; YOUNG ADULT;

EID: 84883673872     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0649     Document Type: Article

References (52)

1. Barrilleaux, B.L., Phinney, D.G., Prockop, D.J., and O'Connor, K.C. Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12, 3007, 2006.
2. Salem, H.K., and Thiemermann, C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28, 585, 2010.
3. Phinney, D.G. Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem 113, 2806, 2012.
4. Ho, A.D., Wagner, W., and Franke, W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10, 320, 2008.
5. Pevsner-Fischer, M., Levin, S., and Zipori, D. The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 7, 560, 2011.
6. Lee, R.H., Hsu, S.C., Munoz, J., Jung, J.S., Lee, N.R., Pochampally, R., and Prockop, D.J. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood 107, 2153, 2006.
7. Zhang, S., Ge, J., Sun, A., Xu, D., Qian, J., Lin, J., Zhao, Y., Hu, H., Li, Y., Wang, K., and Zou, Y. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem 99, 1132, 2006.
8. Colter, D.C., Sekiya, I., and Prockop, D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98, 7841, 2001.
9. Muraglia, A., Cancedda, R., and Quarto, R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113, 1161, 2000.
10. Russell, K.C., Phinney, D.G., Lacey, M.R., Barrilleaux, B.L., Meyertholen, K.E., and O'Connor, K.C. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28, 788, 2010.
11. Russell, K.C., Lacey, M.R., Gilliam, J.K., Tucker, H.A., Phinney, D.G., and O'Connor, K.C. Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnol Bioeng 108, 2716, 2011.
12. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Krause, D.S., Deans, R.J., Keating, A., Prockop, D.J., and Horwitz, E.M. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
13. Hachisuka, H., Mochizuki, Y., Yasunaga, Y., Natsu, K., Sharman, P., Shinomiya, R., and Ochi, M. Flow cytometric discrimination of mesenchymal progenitor cells from bone marrow-adherent cell populations using CD34/44/45(-) and Sca-1( + ) markers. J Orthop Sci 12, 161, 2007.
14. Quirici, N., Soligo, D., Bossolasco, P., Servida, F., Lumini, C., and Deliliers, G.L. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30, 783, 2002.
15. Jones, E.A., Kinsey, S.E., English, A., Jones, R.A., Straszynski, L., Meredith, D.M., Markham, A.F., Jack, A., Emery, P., and McGonagle, D. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46, 3349, 2002.
16. Shih, I.M. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189, 4, 1999.
17. Ouhtit, A., Gaur, R.L., Elmageed, Z.Y.A., Fernando, A., Thouta, R., Trappey, A.K., Abdraboh, M.E., El-Sayyad, H.I., Rao, P., and Raj, M.G. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim Biophys Acta 1795, 130, 2009.
18. Covas, D.T., Panepucci, R.A., Fontes, A.M., Silva, W.A. Jr., Orellana, M.D., and Freitas, M.C.C. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts. Exp Hematol 36, 642, 2008.
19. Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P.-N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., B}uhring, H.-J., Giacobino, J.-P., Lazzari, L., Huard, J., and Péault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
20. Shi, S., and Gronthos, S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18, 696, 2003.
21. Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S., Saggio, I., Tagliafico, E., Ferrari, S., Robey, P.G., Riminucci, M., and Bianco, P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324, 2007.
22. Sorrentino, A., Ferracin, M., Castelli, G., Biffoni, M., Tomaselli, G., Baiocchi, M., Fatica, A., Negrini, M., Peschle, C., and Valtieri, M. Isolation and characterization of CD146 + multipotent mesenchymal stromal cells. Exp Hematol 36, 1035, 2008.
23. Stallcup, W.B. The NG2 proteoglycan: past insights and future prospects. J Neurocytol 31, 423, 2002.
24. Kozanoglu, I., Boga, C., Ozdogu, H., Sozer, O., Maytalman, E., Yazici, A.C., and Sahin, F.I. Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification. Cytotherapy 11, 527, 2009.
25. Sekiya, I., Larson, B.L., Smith, J.R., Pochampally, R., Cui, J.-G., and Prockop, D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20, 530, 2002.
26. Barrilleaux, B.L., Phinney, D.G., Fischer-Valuck, B.W., Russell, K.C., Wang, G., Prockop, D.J., and O'Connor, K.C. Small-molecule antagonist of macrophage migration inhibitory factor enhances migratory response of mesenchymal stem cells to bronchial epithelial cells. Tissue Eng A 15, 2335, 2009.
27. Blanch, H.W., and Clark, D.S. Biochemical Engineering. New York: Marcel Dekker, 1997.
28. Roederer, M. Compensation in Flow Cytometry. Curr Protoc Cytom Chapter 1, Unit 1.14, 2002.
29. Song, H., David, O., Clejan, S., Giordano, C.L., Pappas-Lebeau, H., Xu, L., and O'Connor, K.C. Spatial composition of prostate cancer spheroids in mixed and static cultures. Tissue Eng 10, 1266, 2004.
30. Paradis, H., Liu, C.-Y., Saika, S., Azhar, M., Doetschman, T., Good,W.V., Nayak, R., Laver,N., Kao, C.W.-C., Kao, W.W.-Y., and Gendron, R.L. Tubedown-1 in remodeling of the developing vitreal vasculature in vivo and regulation of capillary outgrowth in vitro. Dev Biol 249, 140, 2002.
31. Traktuev, D.O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R., Johnstone, B.H., and March, K.L. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102, 77, 2008.
32. Zannettino, A.C.W., Paton, S., Arthur, A., Khor, F., Itescu, S., Gimble, J.M., and Gronthos, S. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 214, 413, 2008.
33. Majore, I., Moretti, P., Hass, R., and Kasper, C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal 7, 6, 2009.
34. Haasters, F., Prall, W.C., Anz, D., Bourquin, C., Pautke, C., Endres, S., Mutschler, W., Docheva, D., and Schieker, M. Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat 214, 759, 2009.
35. Markov, V., Kusumi, K., Tadesse, M.G., William, D.A., Hall, D.M., Lounev, V., Carlton, A., Leonard, J., Cohen, R.I., Rappaport, E.F., and Saitta, B. Identification of cord bloodderived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev 16, 53, 2007.
36. Mareddy, S., Crawford, R., Brooke, G., and Xiao, Y. Clonal isolation and characterization of bone marrow stromal cells from patents with osteoarthritis. Tissue Eng 13, 819, 2007.
37. Shapiro, H.M. Practical Flow Cytometry, 4th ed. Hoboken, NJ: Wiley-Liss, 2003.
38. Urbani, S., Caporale, R., Lombardini, L., Bosi, A., and Saccardi, R. Use of CFDA-SE for evaluating the in vitro proliferation pattern of human mesenchymal stem cells. Cryotherapy 8, 243, 2006.
39. Okamoto, T., Aoyama T., Nakayama, T., Nakamata, T., Hosaka, T., Nishijo, K., Nakamura, T., Kiyono, T., and Toguchida, J. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 295, 354, 2002.
40. Stallcup, W.B., and Huang, F.-J. A role for the NG2 proteoglycan in glioma progression. Cell Adh Migr 2, 192, 2008.
41. Chekenya, M., Krakstad, C., Svendsen, A., Netland, I.A., Staalesen, V., Tysnes, B.B., Selheim, F., Wang, J., Sakariassen, P.Ø., Sandal, T., Lønning, P.E., Flatmark, T., Enger, P.Ø., Bjerkvig, R., Sioud, M., and Stallcup, W.B. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 27, 5182, 2008.
42. Song, H., O'Connor, K.C., Papadopoulos, K.D., and Jansen, D.A. Differentiation kinetics of in vitro 3T3-L1 preadipocyte cultures. Tissue Eng 8, 1070, 2002.
43. Wilson, S., Baetge, E., and Stallcup, W.B. Antisera specific for cell lines with mixed neuronal and glial properties. Dev Biol 83, 146, 1981.
44. Gharibi, B., and Hughes, F.J. Effects of medium supplements on proliferation, differentiation potential, and in vitro expansion of mesenchymal stem cells. Stem Cells Transl Med 1, 771, 2012.
45. Delorme, B., Ringe, J., Gallay, N., Le Vern, Y., Kerboeuf, D., Jorgensen, C., Rosset, P., Sensebé, L., Layrolle, P., Hä upl, T., and Charbord, P. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 111, 2631, 2008.
46. Halfon, S., Abramov, N., Grinblat, B., and Ginis, I. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cell Dev 20, 53, 2011.
47. Phinney, D.G. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle 6, 2884, 2007.
48. Bianchi, G., Banfi, A., Mastrogiacomo, M., Notaro, R., Luzzatto, L., Cancedda, R., and Quarto, R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287, 98, 2003.
49. Ringdén, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lö nnies, H., Marschall, H.U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L., and Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81, 1390, 2006.
50. Veryrat-Masson, R., Boiret-Dupré, N., Papatel, C., Descamps, S., Guillouard, L., Guérin, J.J., Pigeon, P., Boisgard, S., Chassagne, J., and Berger, M.G. Mesenchymal content of fresh bone marrow: a proposed quality control method for cell therapy. Br J Haematol 139, 312, 2007.
51. Wagner, W., Bork, S., Horn, P., Krunic, D., Walenda, T., Diehlmann, A., Benes, V., Blake, J., Huber, F.X., Eckstein, V., Boukamp, P., and Ho, A.D. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 4, e5846, 2009.
52. Ezhkova, E., and Fuchs, E. An eye to treating blindness. Nature 446, 567, 2010.